QuarterlyIQ Insights · PCG
Price
Price, valuation, and the composite score on the same time axis. Scroll over the price chart to zoom.
Price
Daily closes. Earnings/event dots inline.
What it's worth (estimated)
A consensus fair price across 6 valuation methods, at three horizons. Current price $16.57. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
No-growth: today's peer multiple on trailing earnings. The headline read.
Embeds projected growth. Leans optimistic by design. Upside context.
Long-thesis check; widest uncertainty.
By method
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Conf. |
|---|---|---|---|---|---|---|
| Mgmt guidance | 12M | $33.39 | 20.2 | 1.65 | Mgmt | 50 |
| Peer P/E | 12M | $32.38 | 20.2 | 1.60 | TTM | 50 |
| Peer P/S | 12M | $35.77 | 3.0 | 11.95 | TTM | 50 |
| PEG | 12M | $38.58 | 24.1 | 1.60 | TTM | 50 |
| Own P/E history | 12M | $19.22 | 12.0 | 1.60 | TTM | 50 |
| triangulated | 12M | $32.73 | 20.2 | 1.62 | Triangulated | 50 |
| Mgmt guidance | 3Y | $41.98 | 20.2 | 2.07 | Mgmt(prov.) | 51 |
| Peer P/E | 3Y | $40.71 | 20.2 | 2.01 | Analyst | 51 |
| Peer P/S | 3Y | $38.51 | 3.0 | 12.87 | Analyst | 51 |
| PEG | 3Y | $48.50 | 24.1 | 2.01 | Analyst | 51 |
| Own P/E history | 3Y | $24.17 | 12.0 | 2.01 | Analyst | 51 |
| Mgmt guidance | 5Y | $48.90 | 20.2 | 2.42 | Mgmt(prov.) | 75 |
| Peer P/E | 5Y | $47.42 | 20.2 | 2.34 | Analyst | 75 |
| Peer P/S | 5Y | $40.46 | 3.0 | 13.52 | Analyst | 75 |
| PEG | 5Y | $56.50 | 24.1 | 2.34 | Analyst | 75 |
| Own P/E history | 5Y | $28.15 | 12.0 | 2.34 | Analyst | 75 |
Composite score history
Daily snapshots of the composite. Zero is the dotted line. Above it leans positive.
P/E history
Monthly trailing P/E with quartile reference lines.
Composite score history currently shows a rolling 60-day window. We're extending it back through full coverage and adding a “consensus-then vs. actual-now” overlay (what our valuation estimate said on a past date versus where the price actually landed).
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.